|15th February 2021||Paul Kim||1,109||Payment by withholding||$161.09||$178,648.81|
|15th February 2021||Hanlin Gao||303||Payment by withholding||$161.09||$48,810.27|
|15th February 2021||Jian Xie||806||Payment by withholding||$161.09||$129,838.54|
|1st February 2021||Jian Xie||504||Payment by withholding||$137.91||$69,506.64|
|21st December 2020||Paul Kim||100||Bona fide gift||$0.00|
|14th December 2020||Jian Xie||22,500||Bona fide gift||$0.00|
|10th December 2020||Paul Kim||16,958||Open or private sale||$51.94||$880,734.08|
|9th December 2020||Paul Kim||10,662||Open or private sale||$51.60||$550,189.05|
|2nd December 2020||Paul Kim||29,319||Open or private sale||$46.62||$1,366,728.64|
|2nd December 2020||Jian Xie||1,000||Open or private sale||$46.00||$46,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 4/10.
Fulgent Genetics, Inc. was founded on May 13, 2016 and is headquartered in Temple City, CA. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software and proprietary laboratory information management systems.